Disease progression status during initial immune checkpoint inhibitor (ICI) affects the clinical outcome of ICI retreatment in advanced non‐small cell lung cancer patients. - Torasawa, Masahiro; Yoshida, Tatsuya; Takeyasu, Yuki; Shimoda, Yukiko; Tateishi, Akiko; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; et al. (Cancer Medicine, 2023)